United States· US:69339-202_885d0fec-f1a6-42f4-8617-1d048cb15ee9
Alprazolam
A alprazolam product containing alprazolam, registered in United States by Natco Pharma USA LLC. The same ATC class is registered in 17 of our 19 countries.
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
Where it is registered
Alprazolam is registered in 17 of 19 countries.
Countries holding a registration under ATC N05BA12 (alprazolam), each read from that country’s own register.
- This record: United States, from FDA National Drug Code directory (United States)
- 9 of them publish a price we can compare per daily dose
Alprazolam · ATC N05BA12
17 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Icelandprice
- Ireland
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Sweden
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of alprazolam costs, country by country.
Normalised to the WHO defined daily dose (1 mg), the median price runs from $0.16 in Spain to $0.53 in Switzerland — a ×3.3 gap.
- 3 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Alprazolam · price per daily dose (1 mg)
USD · FX 28 Sept 2026
- CH Switzerland$0.53
- FR France$0.19
- ES Spain$0.16
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- ALPRAZOLAM
- Manufacturer
- Natco Pharma USA LLC
- Country
- United States (US)
- ATC code
- N05BA12
- ATC class
- Alprazolam
- Defined daily dose
- 1 mg, O
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 6
- ndc116933920201100 TABLET in 1 BOTTLE (69339-202-01)
- ndc116933920205500 TABLET in 1 BOTTLE (69339-202-05)
- ndc1169339202101000 TABLET in 1 BOTTLE (69339-202-10)
- ndc1169339-202-01
- ndc1169339-202-05
- ndc1169339-202-10
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
436 interactions on record for alprazolam.
Graded by severity as the source publishes them — 7 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Alprazolam · interactions on record
436 records
- 7 severe
- 151 moderate
- 32 minor
- 184 info
Most severe, free to view
- KetoconazoleH02CA03severe
- KetoconazoleJ02AB02severe
- FluconazoleJ02AC01severe
- MorphineN02AA01severe
62 more interactions with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Alprazolam in 15 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- SpainALPRAZOLAM ALTER 2 MG COMPRIMIDOS EFGLaboratorios Alter S.A.
- CzechiaALPRAZOLAM KRKAKrka, d.d., Novo mesto, Novo mesto
- FinlandAlprazolam AlternovaAlternova A/S
- SwitzerlandXanax 2 mg, TablettenViatris Pharma GmbH
- PolandXanaxInPharm Sp. z o.o.
- SwedenAlprazolam Krka d.d. 2 mg TablettKrka d.d., Novo mesto
- CanadaAPO-ALPRAZ TSAPOTEX INC
- NorwayXanorViatris Healthcare Limited
Authorised across Europe · EMA
The same active substance is authorised in 30 EEA countries. Names it is sold under:
- Austria · Alprastad, Alprazolam Grindeks
- Belgium · Alpraz, Alpraz Retard
- Bulgaria · Алпразолам Гриндекс, Алпразолам Крка
- Cyprus · Alprazolam Sapiens, Alprazolam Tad
- Czechia · Alprazolam Grindeks, Alprazolam Krka
- Germany · Alprazolam 1 A Pharma, Alprazolam Abz
- Denmark · Alprazolam Grindeks, Alprazolam Krka
- Estonia · Alprazolam Grindeks, Alprazolam Krka
- Spain · Alprazolam Alter, Alprazolam Aurovitas
- Finland · Alprazolam Grindeks, Alprazolam Krka
- France · Alprazolam Arrow, Alprazolam Arrow Lab
- United Kingdom (Northern Ireland) · Xanax
- Greece · Alprazolam Aurobindo, Alprazolam Grindeks
- Croatia · Alprazolam Grindeks, Alprazolam Krka
- Hungary · Alprazolam Alkaloid-Int, Alprazolam Grindeks
- Ireland · Alprazolam Grindeks, Alprazolam Krka
- Iceland · Alprazolam Krka, Alprazolam Wh
- Italy · Alprazig, Alprazolam
- Lithuania · Alprazolam Grindeks, Alprazolam Orion
- Luxembourg · Alpraz, Alpraz Retard
- Latvia · Alprazolam Grindeks, Alprazolam Orion
- Malta · Alprazolam Aurobindo, Xanax
- Netherlands · Alprazolam Aurobindo, Alprazolam Grindeks
- Norway · Xanor, Xanor Depot
- Poland · Afobam, Alpragen
- Portugal · Alprazolam Aurobindo, Alprazolam Aurovitas
- Romania · Alprazolam Grindeks, Alprazolam Lph Labormed
- Sweden · Alprazolam Grindeks, Alprazolam Krka
- Slovenia · Alprazolam Grindeks, Aripsiq
- Slovakia · Alprazolam Grindeks, Frontin
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/815741b6-0d29-4062-bc6c-c7ed27775bfe GET /v1/drugs/815741b6-0d29-4062-bc6c-c7ed27775bfe?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "ORAL",
"source": "ndc",
"strength": "2",
"substance": "ALPRAZOLAM",
"productndc": "69339-202",
"dosage_form": "TABLET",
"dea_schedule": "CIV",
"strength_unit": "mg/1",
"application_number": "ANDA200739",
"marketing_category": "ANDA"
}See everything about alprazolam.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.